cbdMD, Inc. (YCBD)

Market Cap	2.17M
Revenue (ttm)	21.58M
Net Income (ttm)	-25.65M
Shares Out	3.87M
EPS (ttm)	-12.24
PE Ratio	n/a
Forward PE	714.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,692
Open	0.570
Previous Close	0.580
Day's Range	0.560 - 0.580
52-Week Range	0.560 - 1.730
Beta	1.99
Analysts	Strong Buy
Price Target	3.00 (+435.71%)
Earnings Date	Aug 8, 2024

About YCBD

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distri...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 52
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: YCBD

Financial Performance

In 2023, cbdMD's revenue was $24.16 million, a decrease of -31.77% compared to the previous year's $35.40 million. Losses were -$26.94 million, -63.64% less than in 2022.

Analyst Forecast

According to one analyst, the rating for YCBD stock is "Strong Buy" and the 12-month stock price forecast is $3.0.

Price Target

$3.0

(435.71% upside)

Analyst Consensus: Strong Buy